BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38589002)

  • 1. Ablation of IFNγ in myeloid cells suppresses liver inflammation and fibrogenesis in mice with hepatic small heterodimer partner (SHP) deletion.
    Zhu L; Litts B; Wang Y; Rein JA; Atzrodt CL; Chinnarasu S; An J; Thorson AS; Xu Y; Stafford JM
    Mol Metab; 2024 May; 83():101932. PubMed ID: 38589002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.
    Cuño-Gómiz C; de Gregorio E; Tutusaus A; Rider P; Andrés-Sánchez N; Colell A; Morales A; Marí M
    Biol Sex Differ; 2023 Nov; 14(1):85. PubMed ID: 37964320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of diabetes and obesity in mice lacking orphan nuclear receptor small heterodimer partner.
    Park YJ; Kim SC; Kim J; Anakk S; Lee JM; Tseng HT; Yechoor V; Park J; Choi JS; Jang HC; Lee KU; Novak CM; Moore DD; Lee YK
    J Lipid Res; 2011 Dec; 52(12):2234-2244. PubMed ID: 21949050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
    Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y
    J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of hepatic small heterodimer partner ameliorates development of nonalcoholic steatohepatitis in mice.
    Lee YK; Park JE; Lee M; Mifflin R; Xu Y; Novak R; Zhang Y; Hardwick JP
    J Lipid Res; 2023 Nov; 64(11):100454. PubMed ID: 37827334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver.
    Huang J; Iqbal J; Saha PK; Liu J; Chan L; Hussain MM; Moore DD; Wang L
    Hepatology; 2007 Jul; 46(1):147-57. PubMed ID: 17526026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice.
    Caputo M; Andersson E; Xia Y; Hou W; Cansby E; Erikson M; Lind DE; Hallberg B; Amrutkar M; Mahlapuu M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid Trem2 ameliorates the progression of metabolic dysfunction-associated steatotic liver disease by regulating macrophage pyroptosis and inflammation resolution.
    Yu W; Zhang Y; Sun L; Huang W; Li X; Xia N; Chen X; Wikana LP; Xiao Y; Chen M; Han S; Wang Z; Pu L
    Metabolism; 2024 Jun; 155():155911. PubMed ID: 38609037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced ethanol catabolism in orphan nuclear receptor SHP-null mice.
    Park JE; Lee M; Mifflin R; Lee YK
    Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(10):G799-807. PubMed ID: 26968209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver.
    Iacobini C; Menini S; Ricci C; Blasetti Fantauzzi C; Scipioni A; Salvi L; Cordone S; Delucchi F; Serino M; Federici M; Pricci F; Pugliese G
    J Hepatol; 2011 May; 54(5):975-83. PubMed ID: 21145823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
    Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective FXR-SHP Regulation in Obesity Aberrantly Increases
    Seok S; Sun H; Kim YC; Kemper B; Kemper JK
    Diabetes; 2021 Mar; 70(3):733-744. PubMed ID: 33328206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. REV-ERBα Activates C/EBP Homologous Protein to Control Small Heterodimer Partner-Mediated Oscillation of Alcoholic Fatty Liver.
    Yang Z; Tsuchiya H; Zhang Y; Lee S; Liu C; Huang Y; Vargas GM; Wang L
    Am J Pathol; 2016 Nov; 186(11):2909-2920. PubMed ID: 27664470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice.
    Kim KH; Choi S; Zhou Y; Kim EY; Lee JM; Saha PK; Anakk S; Moore DD
    Hepatology; 2017 Aug; 66(2):498-509. PubMed ID: 28378930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease.
    Smalling RV; Delker DA; Zhang Y; Nieto N; McGuiness MS; Liu S; Friedman SL; Hagedorn CH; Wang L
    Am J Physiol Gastrointest Liver Physiol; 2013 Sep; 305(5):G364-74. PubMed ID: 23812039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Mcpip1 in obesity-induced hepatic steatosis as determined by myeloid and liver-specific conditional knockouts.
    Pydyn N; Żurawek D; Kozieł J; Kus E; Wojnar-Lason K; Jasztal A; Fu M; Jura J; Kotlinowski J
    FEBS J; 2021 Nov; 288(22):6563-6580. PubMed ID: 34058074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial products linked to steatohepatitis are reduced by deletion of nuclear hormone receptor SHP in mice.
    Mifflin R; Park JE; Lee M; Jena PK; Wan YY; Barton HA; Aghayev M; Kasumov T; Lin L; Wang X; Novak R; Li F; Huang H; Shriver LP; Lee YK
    J Lipid Res; 2023 Dec; 64(12):100469. PubMed ID: 37922990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. StarD5 levels of expression correlate with onset and progression of steatosis and liver fibrosis.
    Kakiyama G; Minoiwa K; Bai-Kamara N; Hashiguchi T; Pandak WM; Rodriguez-Agudo D
    Am J Physiol Gastrointest Liver Physiol; 2024 Jun; 326(6):G747-G761. PubMed ID: 38591148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
    Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
    Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.